ABSTRACT Titanate nanotubes (TiNTs) with the chemical composition Na2Ti3O7.nH2O (NaTiNT) were obtained through a hydrothermal method in highly alkaline medium. Protonated titanates nanotubes (H-TiNTs), with the composition H2Ti3O7.nH2O, were prepared by ion exchange reaction through a suspension of Na2Ti3OγnH2O nanotubes in HCl medium, promoting the exchange of Na+ ions by H+. Both Na2Ti3O7.nH2O and H2Ti3O7.nH2O products, as well the TiO2 used as raw material for the nanotubes processing, were used as starting material for the solar cells photoelectrodes sensitized using mesoporphyrin extracted from a precursor of cashew nut shell. Exposing the NaTiNT sample to solar radiation of 1258 W/m2, a short-circuit current density (ISC) of 13 µA/cm2 and an open-circuit voltage (VOC) of 370 mV were registered and, a current density of 7.6 µA/cm2 and a voltage of 256 mV for the prototype cell based on H-TiNTs. A current density of 1.1 µA/cm2 and an open-circuit voltage of 1.6 mV were obtained for the cell using TiO2 as electrode.

We assessed at multiple length scales (nanometers to millimeters) the nanocoatings of silver nanoparticles (AgNPs) on model SiO2/Si substrates. The coatings from biogenic AgNPs (from yeasts Rhodotorula glutinis and Rhodotorula mucilaginosa) were compared to those formed from "synthetic" AgNPs capped with citrate and sodium dodecyl sulfate (SDS). With computational analysis of large-field (LF) X-ray images of the whole substrates (5 × 5 mm), we were able to assess the coatings homogeneity, relative amount of AgNPs, and their distribution as agglomerates. Surprisingly, by analyzing more than 100,000 elements (nanoparticles and agglomerates) in each sample, it was observed that the mentioned features have little dependence on the AgNPs morphology and capping agents. All silver nanocoatings resisted when immersed in phosphate-buffered saline medium by forming agglomerates of up to 10 µm2. However, coatings formed with synthetic AgNPs (capped with citrate and SDS) led to a higher antimicrobial efficiency against Staphylococcus aureus.

This work describes the development and characterization of triglyceride-based magnetic nanocomposites for application in magnetic hyperthermia and controlled drug delivery. The magnetic solid lipid nanocomposites (MSLN) constituted by mixtures of trilaurin-tricaprylin and trilaurin-tricaprin have been successfully obtained by emulsification-solvent evaporation method. The developed MSLNs were subjected to an external oscillating magnetic field and showed significant hyperthermia. The samples were exposed to frequencies of 688 and 869 kHz causing, respectively, a temperature increase of 15.5 and 22.7 °C (trilaurin-tricaprylin) and 17.3 and 26.1 °C (trilaurin-tricaprin). Also, in vitro assays in the absence of magnetic field showed that the triglyceride-based formulations were able first to encapsulate and then to sustained release an antitumoural hydrophobic drug. After 72 h of assay trilaurin-tricaprylin and trilaurin-tricaprin released 73 and 55% of their cargo, respectively. In addition, MSLN exhibited low in vitro cytotoxic activity against human neutrophils.

Abstract A growing global trend for maximum use of natural resources through new processes and products has enhanced studies and exploration of renewable natural materials. In this study, cardanol, a component of the cashew nut shell liquid (CNSL), was used as a building block for the development of a thermosetting matrix, which was reinforced by raw and modified sponge gourd fibers (Luffa cylindrica). DSC and TG results showed that among biocomposites, the one reinforced by sponge gourd fibers treated with NaOH 10 wt% (BF10) had the highest thermal stability, besides the best performance in the Tensile testing, showing good incorporation, dispersion, and adhesion to polymer matrix, observed by SEM. After 80 days of simulated soil experiments, it has been discovered that the presence of treated fiber allowed better biodegradability behavior to biocomposites. The biobased thermoset plastic and biocomposites showed a good potential to several applications, such as manufacturing of articles for furniture and automotive industries, especially BF10.

SUMMARY Nanotechnology can be a valuable ally in the treatment of infections. Silver nanoparticles (AgNPs) are structures that have antimicrobial activity. The aim of this study was to produce AgNPs by green methods, characterize these structures, and assess their antimicrobial activity against Escherichia coli associated with the antibiotic ciprofloxacin. AgNPs were characterized by spectroscopic and microscopic techniques. Antimicrobial activity was evaluated by the disk diffusion method against 10 strains of E. coli. The synthesized AgNPs showed a spherical shape and a size of 85.07 ± 12.86 nm (mean ± SD). AgNPs increased the activity of ciprofloxacin by 40% and may represent a new therapeutic option for the treatment of bacterial infections.

Abstract Pluronics® molecules self-assemble in aqueous solution providing a core/shell architecture that improves the solubility of hydrophobic drugs. Binary mixtures of Pluronics® have been studied as drug nanocarriers in order to combine their advantages, like high colloidal stability, small particle size and good solubilisation capacity (Scp). In this work we studied Pluronics® binary mixture, P123 and F127, as nanocarriers of the hydrophobic drug griseofulvin. P123 (E21P67E21) shows a relative good Scp, whereas F127 (E98P67E98) shows a good colloidal stability. According to data, these binary mixtures form stables nano-sized comicelles in aqueous solution. The Scp of the P123/F127 systems at 25 and 37 °C was monitored by UV/Visible spectroscopy, showing good results at both temperatures, as would be expected, since P123/F127 have similar length hydrophobic block. Hydrophobic-dependence and temperature-responsive of the systems were evaluated by CMC, particle size and colloidal stability. Hence, stables P123/F127 comicelles may have potencial as hydrophobic drug delivery.

Nanopartículas de Prata (AgNPs) são estruturas metálicas em escala nanométrica. AgNPs apresentam atividades antimicrobianas contra fungos e bactérias; no entanto, a síntese de AgNPs pode gerar resíduos tóxicos e devido a isso novas rotas utilizando compostos atóxicos têm sido buscadas. O objetivo desse estudo foi sintetizar AgNPs utilizando a ribose como agente redutor e dodecil sulfato de sódio (SDS) como estabilizante e avaliar a atividade antifúngica dessas partículas contra C. albicans e C. tropicalis. Foram sintetizadas nanopartículas estáveis com 12,5 ± 0,2 nm (média ± DP) que apresentaram elevada atividade contra Candida spp. e podem representar boa alternativa no tratamento de infecções fúngicas.

Silver nanoparticles (AgNPs) are metal structures at the nanoscale. AgNPs have exhibited antimicrobial activities against fungi and bacteria; however synthesis of AgNPs can generate toxic waste during the reaction process. Accordingly, new routes using non-toxic compounds have been researched. The proposal of the present study was to synthesize AgNPs using ribose as a reducing agent and sodium dodecyl sulfate (SDS) as a stabilizer. The antifungal activity of these particles against C. albicans and C. tropicalis was also evaluated. Stable nanoparticles 12.5 ± 4.9 nm (mean ± SD) in size were obtained, which showed high activity against Candida spp. and could represent an alternative for fungal infection treatment.

OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopause received transdermal nanostructured formulations of progesterone and estrogens in the forearm daily for 60 months to mimic the normal ovarian secretory pattern. Confocal Raman spectroscopy of hormones in skin layers was performed. Clinical parameters, serum concentrations of estradiol and follicle-stimulating hormone, blood pressure, BI-RADS classification from bilateral mammography, and symptomatic relief were compared between baseline and 60 months post-treatment. Clinicaltrials.gov: NCT02033512. RESULTS: An improvement in climacteric symptoms was reported in 92.5% of women evaluated before and after 60 months of treatment. The serum concentrations of estradiol and follicle-stimulating hormone changed significantly (p<0.05) after treatment; the values of serum follicle-stimulating hormone decreased after 60 months from 82.04±4.9 to 57.12±4.1 IU/mL. A bilateral mammography assessment of the breasts revealed normal results in all women. No adverse health-related events were attributed to this hormone replacement therapy protocol. CONCLUSION: The nanostructured formulation is safe and effective in re-establishing optimal serum levels of estradiol and follicle-stimulating hormone and relieving the symptoms of menopause. This transdermal hormone replacement therapy may alleviate climacteric symptoms in postmenopausal women.